clarithromycin has been researched along with AIDS-Related Opportunistic Infections in 167 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 124 (74.25) | 18.2507 |
| 2000's | 33 (19.76) | 29.6817 |
| 2010's | 10 (5.99) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abrams, G; Adolfsson, E; Agarwal, PK; Akkan, AG; Al Alhareth, NS; Alves, VGL; Armentano, R; Bahroos, E; Baig, M; Baldridge, KK; Barman, S; Bartolucci, C; Basit, A; Bertoli, SV; Bian, L; Bigatti, G; Bobenko, AI; Boix, PP; Bokulic, T; Bolink, HJ; Borowiec, J; Bulski, W; Burciaga, J; Butt, NS; Cai, AL; Campos, AM; Cao, G; Cao, Y; Čapo, I; Caruso, ML; Chao, CT; Cheatum, CM; Chelminski, K; Chen, AJW; Chen, C; Chen, CH; Chen, D; Chen, G; Chen, H; Chen, LH; Chen, R; Chen, RX; Chen, X; Cherdtrakulkiat, R; Chirvony, VS; Cho, JG; Chu, K; Ciurlino, D; Coletta, S; Contaldo, G; Crispi, F; Cui, JF; D'Esposito, M; de Biase, S; Demir, B; Deng, W; Deng, Z; Di Pinto, F; Domenech-Ximenos, B; Dong, G; Drácz, L; Du, XJ; Duan, LJ; Duan, Y; Ekendahl, D; Fan, W; Fang, L; Feng, C; Followill, DS; Foreman, SC; Fortunato, G; Frew, R; Fu, M; Gaál, V; Ganzevoort, W; Gao, DM; Gao, X; Gao, ZW; Garcia-Alvarez, A; Garza, MS; Gauthier, L; Gazzaz, ZJ; Ge, RS; Geng, Y; Genovesi, S; Geoffroy, V; Georg, D; Gigli, GL; Gong, J; Gong, Q; Groeneveld, J; Guerra, V; Guo, Q; Guo, X; Güttinger, R; Guyo, U; Haldar, J; Han, DS; Han, S; Hao, W; Hayman, A; He, D; Heidari, A; Heller, S; Ho, CT; Ho, SL; Hong, SN; Hou, YJ; Hu, D; Hu, X; Hu, ZY; Huang, JW; Huang, KC; Huang, Q; Huang, T; Hwang, JK; Izewska, J; Jablonski, CL; Jameel, T; Jeong, HK; Ji, J; Jia, Z; Jiang, W; Jiang, Y; Kalumpha, M; Kang, JH; Kazantsev, P; Kazemier, BM; Kebede, B; Khan, SA; Kiss, J; Kohen, A; Kolbenheyer, E; Konai, MM; Koniarova, I; Kornblith, E; Krawetz, RJ; Kreouzis, T; Kry, SF; Laepple, T; Lalošević, D; Lan, Y; Lawung, R; Lechner, W; Lee, KH; Lee, YH; Leonard, C; Li, C; Li, CF; Li, CM; Li, F; Li, J; Li, L; Li, S; Li, X; Li, Y; Li, YB; Li, Z; Liang, C; Lin, J; Lin, XH; Ling, M; Link, TM; Liu, HH; Liu, J; Liu, M; Liu, W; Liu, YP; Lou, H; Lu, G; Lu, M; Lun, SM; Ma, Z; Mackensen, A; Majumdar, S; Martineau, C; Martínez-Pastor, JP; McQuaid, JR; Mehrabian, H; Meng, Y; Miao, T; Miljković, D; Mo, J; Mohamed, HSH; Mohtadi, M; Mol, BWJ; Moosavi, L; Mosdósi, B; Nabu, S; Nava, E; Ni, L; Novakovic-Agopian, T; Nyamunda, BC; Nyul, Z; Önal, B; Özen, D; Özyazgan, S; Pajkrt, E; Palazon, F; Park, HW; Patai, Á; Patai, ÁV; Patzke, GR; Payette, G; Pedoia, V; Peelen, MJCS; Pellitteri, G; Peng, J; Perea, RJ; Pérez-Del-Rey, D; Popović, DJ; Popović, JK; Popović, KJ; Posecion, L; Povall, J; Prachayasittikul, S; Prachayasittikul, V; Prat-González, S; Qi, B; Qu, B; Rakshit, S; Ravelli, ACJ; Ren, ZG; Rivera, SM; Salo, P; Samaddar, S; Samper, JLA; Samy El Gendy, NM; Schmitt, N; Sekerbayev, KS; Sepúlveda-Martínez, Á; Sessolo, M; Severi, S; Sha, Y; Shen, FF; Shen, X; Shen, Y; Singh, P; Sinthupoom, N; Siri, S; Sitges, M; Slovak, JE; Solymosi, N; Song, H; Song, J; Song, M; Spingler, B; Stewart, I; Su, BL; Su, JF; Suming, L; Sun, JX; Tantimavanich, S; Tashkandi, JM; Taurbayev, TI; Tedgren, AC; Tenhunen, M; Thwaites, DI; Tibrewala, R; Tomsejm, M; Triana, CA; Vakira, FM; Valdez, M; Valente, M; Valentini, AM; Van de Winckel, A; van der Lee, R; Varga, F; Varga, M; Villarino, NF; Villemur, R; Vinatha, SP; Vincenti, A; Voskamp, BJ; Wang, B; Wang, C; Wang, H; Wang, HT; Wang, J; Wang, M; Wang, N; Wang, NC; Wang, Q; Wang, S; Wang, X; Wang, Y; Wang, Z; Wen, N; Wesolowska, P; Willis, M; Wu, C; Wu, D; Wu, L; Wu, X; Wu, Z; Xia, JM; Xia, X; Xia, Y; Xiao, J; Xiao, Y; Xie, CL; Xie, LM; Xie, S; Xing, Z; Xu, C; Xu, J; Yan, D; Yan, K; Yang, S; Yang, X; Yang, XW; Ye, M; Yin, Z; Yoon, N; Yoon, Y; Yu, H; Yu, K; Yu, ZY; Zhang, B; Zhang, GY; Zhang, H; Zhang, J; Zhang, M; Zhang, Q; Zhang, S; Zhang, W; Zhang, X; Zhang, Y; Zhang, YW; Zhang, Z; Zhao, D; Zhao, F; Zhao, P; Zhao, W; Zhao, Z; Zheng, C; Zhi, D; Zhou, C; Zhou, FY; Zhu, D; Zhu, J; Zhu, Q; Zinyama, NP; Zou, M; Zou, Z | 1 |
| Cross, GB; Hoy, JF; Smibert, OC; Trubiano, JA | 1 |
| Cadilla, AJ; Guerreiro, H; Vaz, AM; Velasco, F | 1 |
| Uthman, MM; Uthman, OA; Yahaya, I | 1 |
| Armon, C; Baker, R; Brooks, JT; Buchacz, K; Palella, FJ; Yangco, BG | 1 |
| Amano, Y; Hasegawa, T; Sakamoto, Y; Tachikawa, N; Yoshimura, Y; Yuya, T | 1 |
| Furusyo, N; Hayashi, J; Murata, M; Ogawa, E; Ohnishi, H; Sawayama, Y; Tatsukawa, M | 1 |
| Kekulé, AS; Kreft, B; Lübbert, C; Marsch, WC; Oehme, A | 1 |
| Bargiacchi, O; Brondolo, R; Brustia, D; Garavelli, PL; Rizzo, G; Salerno, AM | 1 |
| Aïssi, E; Ettahar, N; Huleux, T; Massongo, M; Melliez, H; Pasquet, A; Yazdanpanah, Y | 1 |
| Cajigas-Pezo, D; Lorenzo-Hernandez, A; Rentero-Martínez, Z; Vives-Rivero, GR | 1 |
| Guédénon, A; Hans-Moevi, A; Houessou, R; Ifebe, D; Johnson, RC; Kestens, L; Meyers, WM; Portaels, F | 1 |
| Brade, V; Enzensberger, R; Gruschke, A | 1 |
| Dousman, L; Freund, YR; Mohagheghpour, N | 1 |
| Benson, CA; Chaisson, R; Currier, JS; Flexner, C; Hafner, R; Holland, F; Inderlied, CB; MacGregor, RR; Mahon, LF; Neidig, J; Notario, GF; Williams, PL | 1 |
| Babinchak, TJ; Desimone, JA; Kaulback, KR; Pomerantz, RJ | 1 |
| Chaisson, RE; Karakousis, PC; Moore, RD | 1 |
| Ioannidis, J; Wilkinson, D | 3 |
| Kobayashi, C; Sakai, T; Shinohara, M | 1 |
| Jeyaratnam, D; Keenan, N; Sheerin, NS | 1 |
| Corti, ME; Palmero, DJ | 1 |
| Brouqui, P; Lepidi, H; Moreau, J; Rolain, JM; Rovery, C; Zandotti, C | 1 |
| Tompkins, JC; Witzig, RS | 1 |
| García-Martos, P; Mira, J; Puerto, JL; Ruiz-Aragón, J; Saldarreaga, A | 1 |
| Cercós, A; Montero, M; Navarro, V; Santos, M | 1 |
| Shirasaka, T | 1 |
| Koster, FT; Loss, SD; Mertz, GJ; Nightingale, SD | 1 |
| De Truchis, P; Guesdon, JL; Matsiota-Bernard, P; Nauciel, C; Paraire, F; Saillour, M; Thierry, D | 1 |
| Chin, DP; Hopewell, PC | 1 |
| Baglivo, E; Bouchenaki, N; Chevalley, GF; Kaiser, L; Kress, O | 1 |
| Singh, N; Yu, VL | 1 |
| Delia, S; Iona, E; Mascellino, MT; Mastroianni, CM; Ponzo, R | 1 |
| Lacassin, F; Leport, C; Longuet, P; Perronne, C; Schaffo, D; Vilde, JL | 1 |
| Currier, JS; Davis, RB; Ives, DV | 1 |
| Danner, SA; van der Meer, JT | 1 |
| Musher, DM | 1 |
| Coker, RJ; Hollings, NP; Janes, SM; Main, J; Price, DA | 1 |
| Heifets, L; Sanchez, T; Seay, S; Vanderkolk, J | 1 |
| Cottrell, DG; Dorrell, L; Ellerton, C; Snow, MH | 1 |
| Alder, J; Clement, JC; Hutch, T; Meulbroek, JA | 1 |
| Benson, CA; Chaisson, RE; Craft, JC; Dube, MP; Elkin, S; Heifets, LB; Korvick, JA; Sattler, FR; Smith, T | 1 |
| Goldberger, M; Masur, H | 1 |
| Cardenal, C; Gatell, JM; Guelar, A; Mallolas, J; Miró, JM; Soriano, E; Zamora, L | 1 |
| Wolinsky, E | 1 |
| Bonnet, E; Debat-Zoguereh, D; Gallais, H; Petit, N; Ravaux, I | 1 |
| Chauvin, JP; Dautzenberg, B; Durant, J; Legrand, MF; Meyohas, MC; Reynes, J; Saint-Marc, T; Truffot, C | 1 |
| Brown, M; Brucker, AJ; Frank, I; Goldman, S; Hertle, RW; Maguire, AM; Nichols, C; Saran, BR; Van Uitert, B | 1 |
| Marneff, E; Saint-Marc, T; Touraine, JL | 1 |
| Conville, PS; Husson, RN; Inderlied, CB; Lewis, LL; Pizzo, PA; Ross, LA; Sandelli, S; Venzon, D; Witebsky, FG; Woods, L | 1 |
| Benson, CA | 1 |
| Dupont, B; Goldstein, F; Gonzalez Canali, G; Pialoux, G; Sansonetti, P | 1 |
| Deschênes, J; Miller, M; Phillips, P; Shafran, SD; Toma, E | 1 |
| Bru, JP; Esvant, H; Gaillat, J; Legoupil, I | 1 |
| Alpern, HD; Foltzer, MA; Guiney, WB; Wager, GC | 1 |
| Chene, G; Dupon, M; Lacoste, D; Morlat, P; Pellegrin, JL; Ragnaud, JM | 1 |
| Chauvin, JP; Cotte, L; Dautzenberg, B; De Wit, S; Eliaszewitch, M; Grosset, J; Haniez, F; Meyohas, MC; Rogues, AM; Saint Marc, T | 1 |
| Clark, JA; Margolis, DM | 1 |
| Benson, CA; Feinberg, J; Horsburgh, CR; Ostroff, SM; Spiegel, RA | 1 |
| Inderlied, CB; Nash, KA | 1 |
| Benson, CA; Ellis, LC; Koenig, GI; Trenholme, GM | 1 |
| Baltch, AL; Ford, A; Smith, LC; Smith, RP | 1 |
| Young, LS | 1 |
| McCutchan, JA | 1 |
| Craft, JC; Crampton, S; Cynamon, M; Heifets, L; Henry, D; Jablonowski, H; Jemsek, J; LaMarca, A; Montecalvo, M; Notario, G; Pierce, M; Wormser, GP; Yangco, BG | 1 |
| Bates, JH | 1 |
| Fanning, MM; Fong, IW; Gill, MJ; Lalonde, RG; Phillips, P; Rachlis, AR; Salit, I; Shafran, SD; Singer, J; Tsoukas, CM; Walmsley, SL; Zarowny, DP | 1 |
| Amiel, C; Canton, P; Hoen, B; May, T; Rabaud, C; Sellal, A | 1 |
| Bollemeyer, JG; Kroon, FP; Lowe, SH; Stricker, BH; van 't Wout, JW | 1 |
| Bachelez, H; Dubertret, L; Ducloy, G; Pinquier, L; Rouveau, M; Sibilla, J | 1 |
| Heifets, LB | 1 |
| Jordan, WC | 1 |
| Pijpers, E; Schrey, G; Takx-Köhlen, B; van Rijswijk, RE | 1 |
| Althaus, C; Becker, K; Schimkat, M; Sundmacher, R | 1 |
| Ghebremichael, S; Hoffner, SE; Källenius, G; Svenson, SB | 1 |
| Diemer, PR; Weidle, EG; Zeh, EW | 1 |
| Nelson, MR; Pozniak, A | 1 |
| Cassola, G; Crisalli, MP; Penco, G; Piersantelli, N; Torresin, A | 1 |
| Borderas, F; Delgado, J; Gallardo, JA; Leal, M; Lissen, E; Macías, J; Pineda, JA; Sánchez-Quijano, A | 1 |
| Anderson, J; Helbert, M; Kelleher, P; Parkin, J; Pinching, A; Sweeney, J | 1 |
| Benson, CA; Chaisson, RE; Craft, JC; Fessel, WJ; Keiser, P; Lahart, C; Meek, K; Pierce, M; Ruskin, J; Siepman, N | 1 |
| Ajana, F; Alfandari, S; Chidiac, C; Delaporte, E; Mouton, Y; Senneville, E | 1 |
| Griffith, DE | 1 |
| Böttger, EC; Böttger, O; Stichnoth, DO | 1 |
| Brettle, RP | 1 |
| Beuscart, C; Brel, F; Dautzenberg, B; Doco-Lecompte, T; Grosset, J; May, T; Perronne, C; Saint-Marc, T; Vincent, V | 1 |
| Dautzenberg, B | 2 |
| Cohn, DL | 1 |
| Craft, JC; Fätkenheuer, G; Jablonowski, H; Lines, S; Newell, T; Youle, M | 1 |
| Grosset, J; Ji, B | 1 |
| Baraia-Etxaburu, J; Cisterna, R; Malero, P; Muñoz, J; Santamaría, JM; Teira, R; Unzaga, MJ | 1 |
| Aoki, FY; Deschênes, J; Duperval, R; Lemieux, C; Miller, M; Phillips, P; Schlech, WF; Shafran, SD; Singer, J; Toma, E; Turgeon, F; Zarowny, DP | 1 |
| Butt, AA | 1 |
| Burman, WJ; Cohn, DL; Reves, RR; Rietmeijer, CA | 1 |
| Doucet-Populaire, F; Goujard, C; Lebrun, L; Nordmann, P; Vincent, V | 1 |
| Holmberg, SD; Loveless, MO; Moorman, AC; Navin, TR; Palella, FJ; Von Bargen, JC; Ward, DJ | 1 |
| Clumeck, N; De Wit, S; Payen, MC | 1 |
| de La Blanchardiere, A; Decazes, JM; Herrmann, JL; Hocqueloux, L; Lesprit, P; Modai, J; Zagdanski, AM | 1 |
| Mizutani, S | 1 |
| Koster, F | 1 |
| Böttger, EC; Brown, BA; Burman, WJ; Stone, BL; Wallace, RJ | 1 |
| Burman, WJ; Dunne, EF; Wilson, ML | 1 |
| Burman, WJ; Cohn, DL; Maslow, J; Reves, RR; Rietmeijer, CA; Stone, BL | 1 |
| Bayoumi, AM; Redelmeier, DA | 1 |
| Barzilai, A; Blank-Porat, D; Keller, N; Levi, I; Rubinovich, B; Rubinstein, E | 1 |
| Mukunda, BN; Shekar, R; West, BC | 1 |
| Aberg, JA; Jacobson, MA; Yajko, DM | 1 |
| Carlson, G; Cavanaugh, J; Granneman, GR; Guenther, H; Hsu, A; Leonard, JM; Ouellet, D | 1 |
| Craft, JC; Grosset, JH; Heifets, LB; Notario, GF | 1 |
| Shafran, SD | 1 |
| Evans, TG; Heifets, L; Huycke, M; Kauffman, C; Rimland, D; Ward, TT | 1 |
| Agrawal, M; Bhat, N; Dhawan, VK; Nachum, R; Tolbert, L | 1 |
| Bryan, E; McFarland, J; Sackoff, J; Su, S | 1 |
| Chomyc, S; Davison, E; Fong, IW; Gill, MJ; Lalonde, RG; Phillips, P; Rachlis, AR; Salit, I; Shafran, SD; Singer, J; Talbot, JA; Walmsley, SL | 1 |
| Bombana, E; Chatel, G; Matteelli, A; Pinsi, G; Signorini, L; Tebaldi, A | 1 |
| Dubé, MP; Havlir, DV; Kemper, CA; Leedom, JM; McCutchan, JA; Sattler, FR; See, D; Tilles, JG; Torriani, FJ | 1 |
| Horgen, L; Legrand, E; Rastogi, N | 1 |
| Barker, A; Chatterjee, D; Jarboe, E; Khoo, KH; Kuo, CW; Torrelles, J | 1 |
| Burguière, AM; Eliaszewicz, M; Flahault, A; Fournier, S; Treilhou, MP; Vincent, V | 1 |
| Drusano, G; Hafner, R; Inderlied, CB; Muth, K; Peterson, DM; Standiford, HC; Wright, DJ | 1 |
| Chesnut, J; Child, CC; Clotfelter, J; Cohn, DL; El-Sadr, W; Fisher, EJ; Franchino, B; Gibert, CL; Hafner, R; Heifets, L; Hodges, JS; Horsburgh, CR; Korvick, J; Munroe, D; Peng, GT; Ropka, M | 1 |
| Amsterdam, D; Harmon, BJ; Hewitt, RG; Hsiao, CB; Kaczmarek, SR; Papandonatos, GD; Shelton, MJ | 1 |
| Cohn, DL; Gordin, FM; Horsburgh, CR; Paxton, L; Perry, K; Shafran, SD; Sullam, PM; Wynne, B | 1 |
| Bucher, HC; Craig, BA; Gafni, A; Pfluger, D; Sendi, PP | 1 |
| Fonquernie, L; Frottier, J; Kirstetter, M; Le Van, JC; Meynard, JL; Meyohas, MC; Prévot, S | 1 |
| Guenounou, M; Matsiota-Bernard, P; Onody, C; Zinzendorf, N | 1 |
| Becker, S; Benson, CA; Child, CC; Cohn, DL; Hafner, R; Heifets, L; Hojczyk, P; Korvick, JA; Lederman, MM; Nevin, T; Notario, GF; Powderly, WG; Reichman, RC; Williams, PL; Wynne, BA | 1 |
| Benson, CA; Chernoff, MC; Lederman, MM; MacArthur, RD; MacGregor, RR; Mahon, LF; Purvis, S; Spritzler, J; Yen-Lieberman, B | 1 |
| Khorasheh, S; Lemieux, C; Raboud, JM; Salit, I; Shafran, SD; Singer, J; Thorne, A; Tsoukas, CM; Wu, AW | 1 |
| Craven, DE; Freedberg, KA; Losina, E; Paltiel, AD; Scharfstein, JA; Seage, GR; Weinstein, MC | 1 |
| Bermudez, LE; Inderlied, CB; Nash, K; Petrofsky, M; Young, LS | 1 |
| Benner, R; Bissett, J; Boulos, M; Cahn, P; Dickenson, G; Dunne, M; Fessel, J; Green, S; Hicks, C; Keiser, P; Kumar, P; Lewi, D; Mogyros, M; O'Connor, M; Schneider, MM; Tilles, J; White, AC | 1 |
| Benson, C; Feinberg, J; Fichtenbaum, CJ; Griffiths, JK; Zackin, R | 1 |
| Olivier, D | 1 |
| Asencio Marchante, R; Lissen Otero, E | 1 |
| Benson, C | 1 |
| Cheng, B | 2 |
| Young, A | 1 |
| Prescott, LM | 1 |
| Bowersox, J | 1 |
| Schouten, JT; Whittemore, S | 1 |
| Bartnof, HS | 1 |
| French, P; Prime, K | 1 |
| Holmberg, SD; Moorman, AC | 1 |
| Feinberg, J; Fichtenbaum, CJ; Zackin, R | 1 |
| Carbonara, S; Costa, D; D'Aprile, A; Maggi, P; Monno, R; Pastore, G; Sibilio, G | 1 |
| Gioulekas, J; Hall, A | 1 |
| Yajko, DM | 1 |
| Chaisson, R | 1 |
26 review(s) available for clarithromycin and AIDS-Related Opportunistic Infections
| Article | Year |
|---|---|
Topics: Acetylcholine; Acinetobacter baumannii; Actinobacteria; Action Potentials; Adalimumab; Adaptation, Physiological; Adipates; Administration, Oral; Adolescent; Adrenal Glands; Adsorption; Adult; Aged; Aged, 80 and over; Aging; AIDS-Related Opportunistic Infections; Aldosterone; Amino Acids; Ammonia; Amoxicillin; AMP-Activated Protein Kinases; Animals; Antacids; Anti-Bacterial Agents; Antineoplastic Agents; Antirheumatic Agents; Apgar Score; Area Under Curve; ARNTL Transcription Factors; Arterial Pressure; Arthritis, Juvenile; Athletes; Attention; Biodegradation, Environmental; Biofilms; Biofuels; Biological Therapy; Biomass; Biomimetic Materials; Bioreactors; Birth Weight; Bismuth; Blood Flow Velocity; Bone and Bones; Brain Injuries, Traumatic; Calcium; Calcium Channels; Capsaicin; Carbon; Carcinoma, Hepatocellular; Cardiomegaly, Exercise-Induced; Cartilage; Cartilage, Articular; Case-Control Studies; Catalysis; Cats; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Cell Death; Cell Differentiation; Cell Line, Tumor; Cell Membrane; Charcoal; Chemokine CCL2; Child; Child, Preschool; Chondrogenesis; Chronic Disease; Circadian Clocks; Circadian Rhythm Signaling Peptides and Proteins; Clarithromycin; Coccidioides; Coccidioidomycosis; Cognitive Behavioral Therapy; Coinfection; Color; Coloring Agents; Computer Simulation; Computers, Molecular; Consensus; Corticosterone; Cyclic AMP Response Element-Binding Protein; Cytochrome P-450 Enzyme System; Death, Sudden, Cardiac; Density Functional Theory; Diabetes Mellitus, Type 2; Diabetic Retinopathy; Dialysis Solutions; Disease Models, Animal; Dogs; Dopamine Agonists; Dose-Response Relationship, Drug; Doxorubicin; Drug Administration Schedule; Drug Resistance, Bacterial; Drug Therapy, Combination; Electrocardiography; Electrocardiography, Ambulatory; Electrolytes; Endocardium; Endocrine Disruptors; Endocytosis; Endoscopy, Gastrointestinal; Escherichia coli Proteins; Esters; Evolution, Molecular; Executive Function; Feasibility Studies; Female; Ferric Compounds; Fluorescence; Fluorescent Dyes; Fluorine Radioisotopes; Frailty; Free Radical Scavengers; Gabapentin; Geriatric Assessment; Glucaric Acid; Glucocorticoids; Glucose; Glucose Metabolism Disorders; Halogenated Diphenyl Ethers; Heart Rate; Heart Ventricles; HEK293 Cells; Helicobacter Infections; Helicobacter pylori; Hep G2 Cells; Hepatocytes; Humans; Hungary; Hydrogen Sulfide; Hydrogen-Ion Concentration; Immunologic Factors; Immunomodulation; Immunosuppressive Agents; Independent Living; Indocyanine Green; Infant; Infant Formula; Infant Mortality; Infant, Newborn; Infant, Newborn, Diseases; Inflorescence; Insulin Resistance; Insulins; International Agencies; Iron; Isotonic Solutions; Kidney Failure, Chronic; Kinetics; Lactones; Leukocytes, Mononuclear; Liver Neoplasms; Macular Edema; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Magnetosomes; Male; Medical Audit; Mesenchymal Stem Cells; Metabolic Syndrome; Metformin; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Nude; Middle Aged; Molecular Conformation; Molecular Targeted Therapy; Motor Activity; Multiple Sclerosis; Mycophenolic Acid; Netherlands; Neuropsychological Tests; Nuclear Energy; Organs at Risk; Osteoarthritis; Osteoarthritis, Hip; Oxidation-Reduction; Palladium; Pericardium; Perinatal Death; Peritoneal Dialysis; Phantoms, Imaging; Pharmaceutical Preparations; Phospholipids; Phosphorylation; Physical Conditioning, Human; Physical Endurance; Pilot Projects; Polyketides; Polymers; Positron-Emission Tomography; Postoperative Period; Potassium; Powders; Pramipexole; Predictive Value of Tests; Pregabalin; Pregnancy; Pregnancy Outcome; Protein Structure, Secondary; Proton Pump Inhibitors; Puberty; Pulmonary Circulation; Quality Assurance, Health Care; Quantum Dots; Radiometry; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Intensity-Modulated; Rats, Sprague-Dawley; Receptors, CCR2; Receptors, Transferrin; Regeneration; Registries; Renal Insufficiency, Chronic; Reproducibility of Results; Research Design; Restless Legs Syndrome; Retina; Retinoid X Receptor alpha; Retrospective Studies; Rhenium; Risk Factors; RNA, Messenger; Severity of Illness Index; Sex Factors; Sodium; Sodium Fluoride; Solvents; Spectrometry, Fluorescence; Spectroscopy, Fourier Transform Infrared; Stereoisomerism; Stroke; Structure-Activity Relationship; Tachycardia, Ventricular; Tetracycline; Tetrahydrofolate Dehydrogenase; Tetrahydronaphthalenes; Thermodynamics; Thiophenes; Time Factors; Tinidazole; Tomography, Optical Coherence; Tomography, X-Ray Computed; Topiramate; Toxoplasma; Toxoplasmosis, Cerebral; Transferrin; Treatment Outcome; Up-Regulation; Upper Extremity; Uremia; Uveitis; Vascular Remodeling; Ventricular Fibrillation; Ventricular Function, Left; Ventricular Function, Right; Ventricular Remodeling; Verapamil; Veterans; Visual Acuity; Vitrectomy; Water Pollutants, Chemical; Zea mays; Zirconium | 2019 |
Interventions for the prevention of mycobacterium avium complex in adults and children with HIV.
Topics: Adult; AIDS-Related Opportunistic Infections; Anti-Bacterial Agents; Azithromycin; Child; Clarithromycin; Clofazimine; Humans; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Randomized Controlled Trials as Topic; Rifabutin | 2013 |
Mycobacterium avium complex in patients with HIV infection in the era of highly active antiretroviral therapy.
Topics: Age Factors; AIDS-Related Opportunistic Infections; Anti-Bacterial Agents; Antiretroviral Therapy, Highly Active; CD4 Lymphocyte Count; Clarithromycin; Ethambutol; HIV Infections; HIV-1; Humans; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection | 2004 |
HIV: opportunistic infections.
Topics: Acyclovir; AIDS-Related Opportunistic Infections; Anti-HIV Agents; Anti-Infective Agents; Antitubercular Agents; Antiviral Agents; Atovaquone; Azithromycin; Chickenpox; Clarithromycin; Cytomegalovirus Infections; Drug Therapy, Combination; Ganciclovir; Herpes Simplex; Humans; Mycobacterium avium-intracellulare Infection; Naphthoquinones; Pneumonia, Pneumocystis; Rifabutin; Toxoplasmosis; Trimethoprim, Sulfamethoxazole Drug Combination; Tuberculosis, Pulmonary; Valacyclovir; Valine | 2003 |
HIV: prevention of opportunistic infections.
Topics: 2-Aminopurine; Acyclovir; AIDS-Related Opportunistic Infections; Anti-Infective Agents; Antifungal Agents; Antiprotozoal Agents; Antiretroviral Therapy, Highly Active; Antitubercular Agents; Antiviral Agents; Atovaquone; Azithromycin; Clarithromycin; Cytomegalovirus Infections; Drug Therapy, Combination; Famciclovir; Herpes Simplex; Herpes Zoster; Humans; Mycobacterium avium-intracellulare Infection; Mycoses; Naphthoquinones; Pneumonia, Pneumocystis; Toxoplasmosis; Trimethoprim, Sulfamethoxazole Drug Combination; Tuberculosis, Pulmonary; Valacyclovir; Valine | 2003 |
HIV: prevention of opportunistic infections.
Topics: 2-Aminopurine; Acyclovir; AIDS-Related Opportunistic Infections; Anti-Bacterial Agents; Anti-HIV Agents; Antifungal Agents; Antitubercular Agents; Antiviral Agents; Azithromycin; Chickenpox; Clarithromycin; Cytomegalovirus Infections; Drug Therapy, Combination; Famciclovir; Ganciclovir; Herpes Simplex; Humans; Mycobacterium avium-intracellulare Infection; Mycoses; Pneumonia, Pneumocystis; Rifabutin; Toxoplasmosis; Trimethoprim, Sulfamethoxazole Drug Combination; Tuberculosis, Pulmonary | 2005 |
[Anti-retroviral treatment in patients with AIDS and mycobacterial diseases].
Topics: Acquired Immunodeficiency Syndrome; AIDS-Related Opportunistic Infections; Anti-Bacterial Agents; Anti-Retroviral Agents; Clarithromycin; Drug Interactions; Humans; Mycobacterium Infections; Rifampin; Tuberculosis | 2005 |
[Mycobacterium avium intracellulare pericarditis in patients with AIDS. A case report and literature review].
Topics: Adult; AIDS-Related Opportunistic Infections; Anti-HIV Agents; Clarithromycin; Combined Modality Therapy; Ethambutol; Female; Humans; Lebanon; Mycobacterium avium-intracellulare Infection; Pericardial Effusion; Pericardiocentesis; Pericarditis; Rifabutin; Transfusion Reaction | 2007 |
[Diagnosis and treatment of tuberculosis or Mycobacterium avium-intracellulare complex infection in HIV-infected patients].
Topics: AIDS-Related Opportunistic Infections; Anti-Retroviral Agents; Antitubercular Agents; CD4-Positive T-Lymphocytes; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Ethambutol; HIV Infections; Humans; Lymphocyte Count; Mycobacterium avium-intracellulare Infection; Radiography, Thoracic; Rifabutin; Tuberculosis | 2007 |
Treatment of disseminated disease due to the Mycobacterium avium complex in patients with AIDS.
Topics: AIDS-Related Opportunistic Infections; Anti-Infective Agents; Azithromycin; Clarithromycin; Clinical Trials as Topic; Colony Count, Microbial; Drug Therapy, Combination; Ethambutol; Gentamicins; Humans; Mycobacterium avium-intracellulare Infection; Prospective Studies; Randomized Controlled Trials as Topic | 1994 |
Preventing disseminated Mycobacterium avium complex disease in patients infected with human immunodeficiency virus.
Topics: Adult; AIDS-Related Opportunistic Infections; Anti-Bacterial Agents; Clarithromycin; Humans; Incidence; Mycobacterium avium-intracellulare Infection; Rifabutin; Risk Factors; United States | 1995 |
Treatment and prophylaxis of Mycobacterium avium complex.
Topics: AIDS-Related Opportunistic Infections; Animals; Anti-Bacterial Agents; Azithromycin; Clarithromycin; Clinical Trials as Topic; Humans; Mice; Mycobacterium avium-intracellulare Infection | 1996 |
Clarithromycin against Mycobacterium avium complex infections.
Topics: AIDS-Related Opportunistic Infections; Animals; Anti-Bacterial Agents; Clarithromycin; Drug Resistance; Drug Therapy, Combination; Humans; Mice; Microbial Sensitivity Tests; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection | 1996 |
Against the proposition: all patients with advanced HIV disease should be offered rifabutin prophylaxis.
Topics: AIDS-Related Opportunistic Infections; Anti-Bacterial Agents; Antibiotic Prophylaxis; Azithromycin; Clarithromycin; Drug Resistance, Microbial; Humans; Mycobacterium avium-intracellulare Infection; Rifabutin; Survival Analysis; Treatment Outcome | 1996 |
Nontuberculous mycobacteria.
Topics: AIDS-Related Opportunistic Infections; Anti-Bacterial Agents; Antitubercular Agents; Clarithromycin; Humans; Mycobacterium avium-intracellulare Infection; Mycobacterium Infections, Nontuberculous; Tuberculosis, Pulmonary | 1997 |
Mycobacterium avium intracellulare infection in patients with HIV or AIDS.
Topics: AIDS-Related Opportunistic Infections; Anti-Bacterial Agents; Antibiotic Prophylaxis; Antifungal Agents; Azithromycin; Clarithromycin; Clinical Trials as Topic; Fluconazole; Humans; Immunocompromised Host; Mycobacterium avium-intracellulare Infection; Rifabutin | 1997 |
Rationale for the prevention of disseminated Mycobacterium avium-intracellulare complex disease.
Topics: AIDS-Related Opportunistic Infections; Anti-Bacterial Agents; Azithromycin; CD4 Lymphocyte Count; Clarithromycin; HIV Infections; Humans; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Rifabutin | 1997 |
Prevention strategies for Mycobacterium avium-intracellulare complex (MAC) infection. A review of recent studies in patients with AIDS.
Topics: AIDS-Related Opportunistic Infections; Anti-Bacterial Agents; Azithromycin; Clarithromycin; Controlled Clinical Trials as Topic; Drug Therapy, Combination; HIV Infections; Humans; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Rifabutin | 1997 |
Prevention of the selection of clarithromycin-resistant Mycobacterium avium-intracellulare complex.
Topics: AIDS-Related Opportunistic Infections; Animals; Anti-Bacterial Agents; CD4 Lymphocyte Count; Clarithromycin; Drug Resistance, Microbial; Drug Therapy, Combination; HIV Infections; Humans; Mice; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection | 1997 |
Cervical adenitis due to Mycobacterium fortuitum in patients with acquired immunodeficiency syndrome.
Topics: Abscess; Adult; AIDS-Related Opportunistic Infections; Ciprofloxacin; Clarithromycin; Drainage; Drug Therapy, Combination; Humans; Lymphadenitis; Male; Microbial Sensitivity Tests; Mycobacterium fortuitum; Mycobacterium Infections, Nontuberculous; Tomography, X-Ray Computed | 1998 |
[Manifestations, diagnosis and treatment of non-tuberculous mycobacterial infections in patients with HIV infection].
Topics: Activities of Daily Living; AIDS-Related Opportunistic Infections; Amikacin; Anemia; Anti-Bacterial Agents; Antibiotics, Antitubercular; Antitubercular Agents; Cause of Death; Chemoprevention; Clarithromycin; Cytokines; Drug Therapy, Combination; Ethambutol; Fever; Granulocyte Colony-Stimulating Factor; Health Status; Humans; Immunocompromised Host; Immunotherapy; Incidence; Interferon-gamma; Molecular Biology; Mycobacterium avium-intracellulare Infection; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria; Rifabutin; Tuberculosis; Virulence; Weight Loss | 1997 |
Pulmonary Mycobacterium avium complex disease without dissemination in HIV-infected patients.
Topics: Adult; AIDS-Related Opportunistic Infections; Anti-Bacterial Agents; Antibiotics, Antitubercular; Antitubercular Agents; CD4 Lymphocyte Count; Clarithromycin; Ethambutol; Follow-Up Studies; HIV Infections; Humans; Male; Middle Aged; Mycobacterium avium-intracellulare Infection; Pulmonary Alveoli; Rifabutin; Tomography, X-Ray Computed; Tuberculosis, Pulmonary | 1998 |
[Nontuberculous mycobacteriosis; the present status and in the future. Infection with human immunodeficiency virus (HIV) and nontuberculous mycobacteriosis].
Topics: Adult; AIDS-Related Opportunistic Infections; Anti-Bacterial Agents; Antibiotics, Antitubercular; Azithromycin; Clarithromycin; Humans; Male; Middle Aged; Mycobacterium avium-intracellulare Infection; Rifabutin | 1998 |
Streptomyces pneumonia in a patient with human immunodeficiency virus infection: case report and review of the literature on invasive streptomyces infections.
Topics: Actinomycetales Infections; Adult; AIDS-Related Opportunistic Infections; Anti-Bacterial Agents; Clarithromycin; Humans; Male; Pneumonia, Bacterial; Streptomyces | 1998 |
Neuropsychiatric reaction induced by clarithromycin in a patient on highly active antiretroviral therapy (HAART).
Topics: AIDS-Related Opportunistic Infections; Anti-Bacterial Agents; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Clarithromycin; Drug Interactions; Humans; Male; Middle Aged; Nevirapine; Psychoses, Substance-Induced | 2001 |
In vitro activity of antimicrobial agents against the Mycobacterium avium complex inside macrophages from HIV1-infected individuals: the link to clinical response to treatment?
Topics: Acquired Immunodeficiency Syndrome; AIDS-Related Opportunistic Infections; Anti-Bacterial Agents; Anti-Infective Agents; Bronchoalveolar Lavage Fluid; Clarithromycin; Drug Therapy, Combination; Erythromycin; Fluoroquinolones; Humans; Macrophages; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection | 1992 |
36 trial(s) available for clarithromycin and AIDS-Related Opportunistic Infections
| Article | Year |
|---|---|
Infection fighters. MAC prevention takes a holiday.
Topics: AIDS-Related Opportunistic Infections; Anti-Bacterial Agents; Antiretroviral Therapy, Highly Active; Azithromycin; CD4 Lymphocyte Count; Clarithromycin; Female; Humans; Male; Mycobacterium avium-intracellulare Infection; Placebos; Viral Load | 2000 |
A prospective, randomized trial examining the efficacy and safety of clarithromycin in combination with ethambutol, rifabutin, or both for the treatment of disseminated Mycobacterium avium complex disease in persons with acquired immunodeficiency syndrome
Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS-Related Opportunistic Infections; Clarithromycin; Double-Blind Method; Drug Resistance, Bacterial; Drug Therapy, Combination; Ethambutol; Female; Humans; Male; Middle Aged; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Prospective Studies; Rifabutin | 2003 |
Clarithromycin therapy for bacteremic Mycobacterium avium complex disease. A randomized, double-blind, dose-ranging study in patients with AIDS. AIDS Clinical Trials Group Protocol 157 Study Team.
Topics: Adult; AIDS-Related Opportunistic Infections; Bacteremia; Clarithromycin; Colony Count, Microbial; Double-Blind Method; Drug Administration Schedule; Drug Resistance, Microbial; Female; Humans; Male; Mycobacterium avium-intracellulare Infection; Prospective Studies; Survival Analysis | 1994 |
[Treatment with clarithromycin of 173 HIV+ patients with disseminated Mycobacterium avium intracellulare infection].
Topics: Adolescent; Adult; AIDS-Related Opportunistic Infections; Anti-Infective Agents; Antitubercular Agents; Child; Clarithromycin; Clofazimine; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Fluoroquinolones; Hearing Disorders; Humans; Liver Function Tests; Male; Middle Aged; Minocycline; Mycobacterium avium-intracellulare Infection; Recurrence; Treatment Outcome | 1994 |
[Mycobacterium avium intracellulare infections. Treatment with a clarithromycin-clofazimine combination. 18 cases].
Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS-Related Opportunistic Infections; Chemical and Drug Induced Liver Injury; Clarithromycin; Clofazimine; Drug Therapy, Combination; Humans; Male; Middle Aged; Mycobacterium avium-intracellulare Infection | 1993 |
Orally administered clarithromycin for the treatment of systemic Mycobacterium avium complex infection in children with acquired immunodeficiency syndrome.
Topics: Administration, Oral; Adolescent; AIDS-Related Opportunistic Infections; Child; Child, Preschool; Clarithromycin; Female; Humans; Infant; Male; Microbial Sensitivity Tests; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Recurrence | 1994 |
Uveitis and pseudojaundice during a regimen of clarithromycin, rifabutin, and ethambutol. MAC Study Group of the Canadian HIV Trials Network.
Topics: AIDS-Related Opportunistic Infections; Bacteremia; Clarithromycin; Drug Therapy, Combination; Ethambutol; Humans; Jaundice; Mycobacterium avium-intracellulare Infection; Prospective Studies; Rifabutin; Uveitis | 1994 |
Clarithromycin and other antimicrobial agents in the treatment of disseminated Mycobacterium avium infections in patients with acquired immunodeficiency syndrome.
Topics: Adult; AIDS-Related Opportunistic Infections; Anti-Infective Agents; Clarithromycin; Drug Resistance, Microbial; Female; Humans; Male; Middle Aged; Mycobacterium avium-intracellulare Infection | 1993 |
A randomized trial of clarithromycin as prophylaxis against disseminated Mycobacterium avium complex infection in patients with advanced acquired immunodeficiency syndrome.
Topics: Acquired Immunodeficiency Syndrome; Adult; Aged; AIDS-Related Opportunistic Infections; Anti-Bacterial Agents; Clarithromycin; Disease-Free Survival; Double-Blind Method; Drug Resistance, Microbial; Female; Humans; Male; Middle Aged; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Prospective Studies; Survival Analysis | 1996 |
A comparison of two regimens for the treatment of Mycobacterium avium complex bacteremia in AIDS: rifabutin, ethambutol, and clarithromycin versus rifampin, ethambutol, clofazimine, and ciprofloxacin. Canadian HIV Trials Network Protocol 010 Study Group.
Topics: Adult; AIDS-Related Opportunistic Infections; Anti-Bacterial Agents; Antitubercular Agents; Bacteremia; Ciprofloxacin; Clarithromycin; Clofazimine; Drug Therapy, Combination; Ethambutol; Female; Humans; Male; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Rifabutin; Rifampin; Survival Analysis; Treatment Outcome; Uveitis | 1996 |
Clarithromycin and ethambutol with or without clofazimine for the treatment of bacteremic Mycobacterium avium complex disease in patients with HIV infection.
Topics: Adult; AIDS-Related Opportunistic Infections; Anti-Bacterial Agents; Antitubercular Agents; Clarithromycin; Clofazimine; Drug Resistance, Microbial; Drug Therapy, Combination; Ethambutol; Female; Humans; Male; Mycobacterium avium-intracellulare Infection | 1997 |
Comparison of combination therapy regimens for treatment of human immunodeficiency virus-infected patients with disseminated bacteremia due to Mycobacterium avium. ANRS Trial 033 Curavium Group. Agence Nationale de Recherche sur le Sida.
Topics: Adult; AIDS-Related Opportunistic Infections; Bacteremia; Clarithromycin; Clofazimine; Drug Therapy, Combination; Ethambutol; Female; Humans; Male; Mycobacterium avium-intracellulare Infection; Prospective Studies; Recurrence; Rifabutin | 1997 |
Ancillary benefits of Mycobacterium avium-intracellulare complex prophylaxis with clarithromycin in HIV-infected patients.
Topics: Adult; AIDS-Related Opportunistic Infections; Animals; Anti-Bacterial Agents; CD4 Lymphocyte Count; Clarithromycin; Female; Giardia lamblia; Giardiasis; HIV Infections; Humans; Lymphoma, AIDS-Related; Male; Middle Aged; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Pneumocystis; Pneumonia; Pneumonia, Pneumocystis; Sarcoma, Kaposi | 1997 |
Determinants of rifabutin-associated uveitis in patients treated with rifabutin, clarithromycin, and ethambutol for Mycobacterium avium complex bacteremia: a multivariate analysis. Canadian HIV Trials Network Protocol 010 Study Group.
Topics: Adult; AIDS-Related Opportunistic Infections; Anti-Bacterial Agents; Antibiotics, Antitubercular; Antitubercular Agents; Bacteremia; Clarithromycin; Drug Therapy, Combination; Ethambutol; Female; Humans; Incidence; Male; Middle Aged; Multivariate Analysis; Mycobacterium avium-intracellulare Infection; Rifabutin; Risk Factors; Uveitis | 1998 |
Eradication of AIDS-related disseminated mycobacterium avium complex infection after 12 months of antimycobacterial therapy combined with highly active antiretroviral therapy.
Topics: Adult; AIDS-Related Opportunistic Infections; Anti-Bacterial Agents; Anti-HIV Agents; Clarithromycin; Drug Therapy, Combination; Ethambutol; Female; Humans; Lamivudine; Male; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Rifabutin; Stavudine; Zidovudine | 1998 |
Pharmacokinetic interaction between ritonavir and clarithromycin.
Topics: Adult; AIDS-Related Opportunistic Infections; Anti-Bacterial Agents; Clarithromycin; Cross-Over Studies; Drug Administration Schedule; Drug Interactions; Female; Half-Life; HIV Protease Inhibitors; Humans; Hydroxylation; Male; Middle Aged; Mycobacterium avium-intracellulare Infection; Reference Values; Ritonavir | 1998 |
Clarithromycin resistance and susceptibility patterns of Mycobacterium avium strains isolated during prophylaxis for disseminated infection in patients with AIDS.
Topics: Adolescent; Adult; AIDS-Related Opportunistic Infections; Anti-Bacterial Agents; Antitubercular Agents; Bacteremia; Clarithromycin; Double-Blind Method; Drug Resistance, Microbial; Female; Humans; Male; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Prospective Studies | 1998 |
Randomized, open-label trial of azithromycin plus ethambutol vs. clarithromycin plus ethambutol as therapy for Mycobacterium avium complex bacteremia in patients with human immunodeficiency virus infection. Veterans Affairs HIV Research Consortium.
Topics: Adult; AIDS-Related Opportunistic Infections; Anti-Bacterial Agents; Antitubercular Agents; Azithromycin; Bacteremia; Clarithromycin; Drug Therapy, Combination; Ethambutol; HIV-1; Humans; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Time Factors; Treatment Outcome | 1998 |
Prophylaxis for opportunistic infections among HIV-infected patients receiving medical care.
Topics: Adolescent; Adult; AIDS-Related Opportunistic Infections; Analysis of Variance; Anti-Infective Agents; Atovaquone; Azithromycin; Clarithromycin; Dapsone; Ethnicity; Female; HIV Infections; Humans; Longitudinal Studies; Male; Medical Records; Mycobacterium avium-intracellulare Infection; Naphthoquinones; New York City; Pentamidine; Pneumonia, Pneumocystis; Practice Guidelines as Topic; Regression Analysis; Rifabutin; Risk-Taking; Time Factors; Toxoplasmosis; Trimethoprim, Sulfamethoxazole Drug Combination; United States; United States Public Health Service | 1998 |
Does in vitro susceptibility to rifabutin and ethambutol predict the response to treatment of Mycobacterium avium complex bacteremia with rifabutin, ethambutol, and clarithromycin? Canadian HIV Trials Network Protocol 010 Study Group.
Topics: AIDS-Related Opportunistic Infections; Bacteremia; Clarithromycin; Drug Therapy, Combination; Ethambutol; Humans; Microbial Sensitivity Tests; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Predictive Value of Tests; Rifabutin | 1998 |
Successful short-term suppression of clarithromycin-resistant Mycobacterium avium complex bacteremia in AIDS. California Collaborative Treatment Group.
Topics: AIDS-Related Opportunistic Infections; Bacteremia; Ciprofloxacin; Clarithromycin; Clofazimine; Drug Resistance, Microbial; Drug Therapy, Combination; Ethambutol; Humans; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Rifabutin | 1999 |
Effect of adding clofazimine to combined clarithromycin-ethambutol therapy for Mycobacterium avium complex septicemia in AIDS patients.
Topics: Aged; AIDS-Related Opportunistic Infections; Anti-Inflammatory Agents, Non-Steroidal; Bacteremia; Clarithromycin; Clofazimine; Drug Therapy, Combination; Ethambutol; Female; Humans; Male; Middle Aged; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Survival Analysis | 1999 |
A prospective randomized trial of four three-drug regimens in the treatment of disseminated Mycobacterium avium complex disease in AIDS patients: excess mortality associated with high-dose clarithromycin. Terry Beirn Community Programs for Clinical Resear
Topics: Adult; AIDS-Related Opportunistic Infections; Anti-Bacterial Agents; Antibiotics, Antitubercular; Clarithromycin; Clofazimine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Male; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Patient Compliance; Prospective Studies; Rifabutin; Survivors; Treatment Outcome | 1999 |
A randomized, placebo-controlled study of rifabutin added to a regimen of clarithromycin and ethambutol for treatment of disseminated infection with Mycobacterium avium complex.
Topics: Adolescent; Adult; AIDS-Related Opportunistic Infections; Antitubercular Agents; Child; Clarithromycin; Drug Resistance, Microbial; Drug Therapy, Combination; Ethambutol; Female; Humans; Male; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Prospective Studies; Rifabutin; Survival Analysis | 1999 |
Comparison of clarithromycin-sensitive and clarithromycin-resistant Mycobacterium avium strains isolated from AIDS patients during therapy regimens including clarithromycin.
Topics: AIDS-Related Opportunistic Infections; Anti-Bacterial Agents; Antitubercular Agents; Bacteremia; Cell Line; Clarithromycin; DNA, Bacterial; Drug Therapy, Combination; Humans; Microbial Sensitivity Tests; Monocytes; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Nucleic Acid Hybridization; Random Amplified Polymorphic DNA Technique; Recurrence; Tumor Necrosis Factor-alpha | 2000 |
Clarithromycin or rifabutin alone or in combination for primary prophylaxis of Mycobacterium avium complex disease in patients with AIDS: A randomized, double-blind, placebo-controlled trial. The AIDS Clinical Trials Group 196/Terry Beirn Community Progra
Topics: Adult; AIDS-Related Opportunistic Infections; Anti-Bacterial Agents; Antibiotics, Antitubercular; Clarithromycin; Double-Blind Method; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Humans; Male; Microbial Sensitivity Tests; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Prospective Studies; Rifabutin | 2000 |
Effects of Mycobacterium avium complex-infection treatment on cytokine expression in human immunodeficiency virus-infected persons: results of AIDS clinical trials group protocol 853.
Topics: Adult; AIDS-Related Opportunistic Infections; Anti-Bacterial Agents; Antitubercular Agents; Clarithromycin; Cytokines; Ethambutol; Humans; Interleukin-1; Interleukin-6; Mycobacterium avium-intracellulare Infection; Pilot Projects; Rifabutin; RNA, Viral; Tumor Necrosis Factor-alpha; Viral Load | 2000 |
Symptomatic and health status outcomes in the Canadian randomized MAC treatment trial (CTN010). Canadian HIV Trials Network Protocol 010 Study Group.
Topics: Adolescent; Adult; AIDS-Related Opportunistic Infections; Antitubercular Agents; Bacteremia; Canada; Ciprofloxacin; Clarithromycin; Clofazimine; Drug Therapy, Combination; Ethambutol; Health Status; Humans; Mycobacterium avium-intracellulare Infection; Outcome and Process Assessment, Health Care; Rifabutin; Rifampin; Treatment Outcome | 2000 |
A randomized, double-blind trial comparing azithromycin and clarithromycin in the treatment of disseminated Mycobacterium avium infection in patients with human immunodeficiency virus.
Topics: Adult; AIDS-Related Opportunistic Infections; Anti-Bacterial Agents; Azithromycin; Clarithromycin; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Ethambutol; Female; Gastrointestinal Diseases; Humans; Male; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Survival Analysis; Treatment Outcome | 2000 |
Rifabutin but not clarithromycin prevents cryptosporidiosis in persons with advanced HIV infection.
Topics: Adolescent; Adult; Aged; AIDS-Related Opportunistic Infections; Animals; Anti-Bacterial Agents; Antibiotic Prophylaxis; Child; Clarithromycin; Cryptosporidiosis; Cryptosporidium parvum; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Rifabutin | 2000 |
Clarithromycin for MAC.
Topics: AIDS-Related Opportunistic Infections; Clarithromycin; Humans; Mycobacterium avium-intracellulare Infection | 1995 |
Clarithromycin and MAC.
Topics: AIDS-Related Opportunistic Infections; Anti-Bacterial Agents; Clarithromycin; Double-Blind Method; Humans; Mycobacterium avium-intracellulare Infection; Prospective Studies | 1996 |
Different clarithromycin doses affect mortality.
Topics: AIDS-Related Opportunistic Infections; Anti-Bacterial Agents; Antitubercular Agents; Clarithromycin; Dose-Response Relationship, Drug; Drug Therapy, Combination; Humans; Mycobacterium avium-intracellulare Infection; Randomized Controlled Trials as Topic; Risk Factors; Survival Rate | 1997 |
Researchers find new drugs to fight MAC.
Topics: AIDS-Related Opportunistic Infections; Animals; Antitubercular Agents; CD4 Lymphocyte Count; Clarithromycin; Half-Life; Humans; Mycobacterium avium-intracellulare Infection; Placebos; Randomized Controlled Trials as Topic; Rifabutin; Rifampin | 1995 |
FDA approves Biaxin for MAC prophylaxis. Food and Drug Administration.
Topics: AIDS-Related Opportunistic Infections; Clarithromycin; Clinical Trials as Topic; Drug Approval; Humans; Mycobacterium avium-intracellulare Infection; Placebos; Randomized Controlled Trials as Topic; United States Food and Drug Administration | 1995 |
Clarithromycin is effective against M. avium complex in AIDS.
Topics: AIDS-Related Opportunistic Infections; Clarithromycin; Humans; Mycobacterium avium-intracellulare Infection | 1992 |
105 other study(ies) available for clarithromycin and AIDS-Related Opportunistic Infections
| Article | Year |
|---|---|
Short Communication: Mycobacterium avium Complex Infection and Immune Reconstitution Inflammatory Syndrome Remain a Challenge in the Era of Effective Antiretroviral Therapy.
Topics: Adult; AIDS-Related Opportunistic Infections; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Clarithromycin; Drug Therapy, Combination; Ethambutol; Female; HIV Infections; Humans; Immune Reconstitution Inflammatory Syndrome; Male; Middle Aged; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Rifabutin | 2017 |
Capsule endoscopy in the diagnosis of disseminated
Topics: Abdominal Pain; Adult; AIDS-Related Opportunistic Infections; Anti-Bacterial Agents; Capsule Endoscopy; CD4 Lymphocyte Count; Clarithromycin; Drug Therapy, Combination; Ethambutol; Fever; HIV Infections; Humans; Intestinal Diseases; Male; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Rifabutin; Treatment Outcome; Vomiting | 2017 |
Is primary mycobacterium avium complex prophylaxis necessary in patients with CD4 <50 cells/μL who are virologically suppressed on cART?
Topics: Adult; Aged; AIDS-Related Opportunistic Infections; Anti-Bacterial Agents; Anti-HIV Agents; Antibiotic Prophylaxis; Antiretroviral Therapy, Highly Active; Azithromycin; CD4 Lymphocyte Count; Clarithromycin; Female; Follow-Up Studies; HIV Infections; Humans; Incidence; Male; Middle Aged; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Retrospective Studies; Rifabutin; RNA, Viral; United States; Viral Load | 2014 |
Image of the month: Disseminated Nontuberculous Mycobacteriosis.
Topics: Adult; AIDS-Related Opportunistic Infections; Anemia; Antibiotics, Antitubercular; Biopsy; Blood; Clarithromycin; Endoscopy, Gastrointestinal; Ethambutol; Feces; HIV-1; Humans; Male; Mycobacterium avium Complex; Mycobacterium Infections, Nontuberculous; Pleural Effusion; Rifabutin; Sputum; Treatment Outcome | 2015 |
[AIDS-related Mycobacterium avium infection dissemination in a patient with endobronchial lesions associated with immune reconstitution inflammatory syndrome].
Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS-Related Opportunistic Infections; Anti-Bacterial Agents; Antiretroviral Therapy, Highly Active; Bronchial Diseases; Bronchitis; Clarithromycin; Female; HIV-1; Humans; Immune Reconstitution Inflammatory Syndrome; Mycobacterium avium-intracellulare Infection; Streptomycin; Treatment Outcome | 2008 |
[37-year old patient with fever, diarrhea and lymphadenopathy].
Topics: Adult; AIDS Serodiagnosis; AIDS-Related Opportunistic Infections; Anti-Bacterial Agents; Antifungal Agents; Antiretroviral Therapy, Highly Active; Candidiasis, Oral; Ciprofloxacin; Clarithromycin; Diagnosis, Differential; Diarrhea; Drug Therapy, Combination; Fever of Unknown Origin; Fluconazole; Giardia lamblia; Giardiasis; HIV Seropositivity; HIV-1; Homosexuality, Male; Humans; Immunoblotting; Lymphatic Diseases; Male; Metronidazole; Omeprazole | 2010 |
[Whipple's disease in an AIDS patient with Kaposi's sarcoma. Report of a case].
Topics: Adult; AIDS-Related Opportunistic Infections; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Antineoplastic Combined Chemotherapy Protocols; Antiretroviral Therapy, Highly Active; Clarithromycin; Duodenum; Humans; Male; Sarcoma, Kaposi; Skin Neoplasms; Tropheryma; Whipple Disease | 2010 |
[Immune reconstitution syndrome related to a Mycobacterium avium complex infection, revealed by a mono-adenitis].
Topics: Abscess; Adult; AIDS-Related Opportunistic Infections; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Antitubercular Agents; Axilla; Clarithromycin; Darunavir; Dideoxynucleosides; Enfuvirtide; Ethambutol; HIV Envelope Protein gp41; HIV-1; Humans; Immune Reconstitution Inflammatory Syndrome; Isoniazid; Lamivudine; Lymph Node Excision; Lymphadenitis; Male; Mycobacterium avium-intracellulare Infection; Peptide Fragments; Pyrazinamide; Rifampin; Ritonavir; Streptomycin; Sulfonamides | 2011 |
[Swelling of right knee in an immunologically compromised patient].
Topics: Adult; AIDS-Related Opportunistic Infections; Antitubercular Agents; Arthritis, Infectious; Bacteremia; Candidiasis, Oral; Clarithromycin; Drug Therapy, Combination; Ethambutol; Humans; Immunocompromised Host; Isoniazid; Knee Joint; Male; Mycobacterium Infections, Nontuberculous; Mycobacterium kansasii; Radiography; Rifampin; Tuberculosis, Osteoarticular | 2012 |
Disseminated Mycobacterium ulcerans disease in an HIV-positive patient: a case study.
Topics: Adult; AIDS-Related Opportunistic Infections; Antitubercular Agents; Clarithromycin; Drug Therapy, Combination; Ethambutol; Female; Humans; Mycobacterium Infections, Nontuberculous; Mycobacterium ulcerans; Polymerase Chain Reaction; Rifampin | 2002 |
[Osteomyelitis of the tibial head caused by Mycobacterium haemophilium in a patient with AIDS].
Topics: Abscess; AIDS-Related Opportunistic Infections; Anti-Infective Agents; Antitubercular Agents; Clarithromycin; Drug Therapy, Combination; Ethambutol; Humans; Immunocompromised Host; Levofloxacin; Male; Middle Aged; Mycobacterium haemophilum; Mycobacterium Infections; Ofloxacin; Osteomyelitis; Recurrence; Rifabutin; Tibia | 2002 |
Prophylactic clarithromycin to treat mycobacterium avium in HIV patients receiving zidovudine may significantly increase mortality by suppressing lymphopoiesis and hematopoiesis.
Topics: AIDS-Related Opportunistic Infections; Animals; Anti-Bacterial Agents; Anti-HIV Agents; Cell Line; Clarithromycin; Dose-Response Relationship, Drug; Female; Hematopoiesis; HIV Infections; Humans; Lymphocyte Activation; Lymphopoiesis; Mice; Mice, Inbred BALB C; Mycobacterium avium-intracellulare Infection; Zidovudine | 2002 |
Treatment of Mycobacterium avium complex immune reconstitution disease in HIV-1-infected individuals.
Topics: Adult; AIDS-Related Opportunistic Infections; Anti-Infective Agents; Antiretroviral Therapy, Highly Active; Ciprofloxacin; Clarithromycin; Decision Trees; Diagnosis, Differential; HIV-1; Humans; Male; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Radiography | 2003 |
Mycobacterium peregrinum infection in a patient with AIDS.
Topics: Adult; AIDS-Related Opportunistic Infections; Anti-Bacterial Agents; beta-Lactams; Clarithromycin; Drug Therapy, Combination; Female; Follow-Up Studies; HIV; Humans; Imipenem; Lactams; Mycobacterium fortuitum; Mycobacterium Infections, Nontuberculous; RNA, Viral | 2005 |
Mycobacterium simiae: a previously undescribed pathogen in peritoneal dialysis peritonitis.
Topics: Adult; AIDS-Related Opportunistic Infections; Amikacin; Amoxicillin; Antiretroviral Therapy, Highly Active; Candidiasis, Oral; Ciprofloxacin; Clarithromycin; Drug Therapy, Combination; Equipment Contamination; Gentamicins; Humans; Immunocompromised Host; Kidney Failure, Chronic; Male; Mycobacterium; Mycobacterium Infections; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis; Pneumonia, Pneumocystis; Renal Dialysis; Rifabutin; Vancomycin | 2005 |
Bartonella quintana coinfection with Mycobacterium avium complex and CMV in an AIDS patient: case presentation.
Topics: AIDS-Related Opportunistic Infections; Angiomatosis, Bacillary; Anti-Bacterial Agents; Antibodies, Viral; Bartonella quintana; Biopsy; Clarithromycin; Cytomegalovirus; Cytomegalovirus Infections; Dermatologic Surgical Procedures; Ethambutol; Humans; Male; Middle Aged; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Rifabutin; Skin; Treatment Outcome | 2006 |
Mycobacterium kansasii in HIV patients: clarithromycin and antiretroviral effects.
Topics: Adult; AIDS-Related Opportunistic Infections; Anti-Bacterial Agents; Antiretroviral Therapy, Highly Active; Antitubercular Agents; CD4 Lymphocyte Count; Clarithromycin; Female; Humans; Louisiana; Male; Microbial Sensitivity Tests; Middle Aged; Mycobacterium Infections, Nontuberculous; Mycobacterium kansasii; Retrospective Studies; Treatment Outcome | 2007 |
[Arthritis due to Mycobacterium kansasii in a woman with human immunodeficiency virus infection].
Topics: Adult; AIDS-Related Opportunistic Infections; Anti-Bacterial Agents; Arthritis, Infectious; Clarithromycin; Ethambutol; Female; Humans; Knee Joint; Mycobacterium Infections, Nontuberculous; Mycobacterium kansasii; Rifabutin; Synovial Fluid | 2007 |
Clarithromycin-induced mania in two patients with AIDS.
Topics: Adult; AIDS-Related Opportunistic Infections; Bipolar Disorder; Clarithromycin; Humans; Male; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection | 1995 |
Mycobacterium genavense infection in a patient with AIDS who was successfully treated with clarithromycin.
Topics: Adult; AIDS-Related Opportunistic Infections; Clarithromycin; Humans; Male; Mycobacterium Infections | 1995 |
How to treat bacteraemic Mycobacterium avium complex disease.
Topics: AIDS-Related Opportunistic Infections; Anti-Bacterial Agents; Bacteremia; Clarithromycin; Drug Therapy, Combination; Humans; Mycobacterium avium-intracellulare Infection; Randomized Controlled Trials as Topic; Rifabutin; Survival Rate; Treatment Outcome | 1995 |
[Uveitis associated with rifabutin treatment. Apropos of 3 patients].
Topics: Adult; AIDS-Related Opportunistic Infections; Clarithromycin; Drug Therapy, Combination; Ethambutol; Female; Humans; Mycobacterium avium-intracellulare Infection; Rifabutin; Uveitis, Anterior | 1995 |
Clarithromycin therapy for Mycobacterium avium complex bacteremia.
Topics: AIDS-Related Opportunistic Infections; Bacteremia; Clarithromycin; Drug Administration Schedule; Humans; Mycobacterium avium-intracellulare Infection; Treatment Outcome | 1995 |
Infections due to Rhodococcus equi in three HIV-infected patients: microbiological findings and antibiotic susceptibility.
Topics: Actinomycetales Infections; Adult; AIDS-Related Opportunistic Infections; Anti-Bacterial Agents; Azithromycin; Bacteremia; Bronchoalveolar Lavage Fluid; Clarithromycin; Drug Resistance, Microbial; Drug Synergism; Drug Therapy, Combination; Erythromycin; Female; Gentamicins; HIV Infections; Humans; Imipenem; Male; Pleurisy; Pneumonia, Bacterial; Rhodococcus equi; Rifampin; Sputum; Teicoplanin; Vancomycin | 1994 |
Clarithromycin-minocycline combination as salvage therapy for toxoplasmosis in patients infected with human immunodeficiency virus.
Topics: Adult; AIDS-Related Opportunistic Infections; Clarithromycin; Drug Combinations; Female; Humans; Male; Minocycline; Salvage Therapy; Toxoplasmosis | 1995 |
Impact of clarithromycin and azithromycin on patterns of treatment and survival among AIDS patients with disseminated Mycobacterium avium complex.
Topics: Adult; AIDS-Related Opportunistic Infections; Azithromycin; Clarithromycin; Cohort Studies; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Multivariate Analysis; Mycobacterium avium-intracellulare Infection; Retrospective Studies; Survival Rate | 1995 |
Clarithromycin therapy for Mycobacterium avium complex bacteremia.
Topics: AIDS-Related Opportunistic Infections; Bacteremia; Clarithromycin; Drug Administration Schedule; Humans; Mycobacterium avium-intracellulare Infection; Treatment Outcome | 1995 |
Clarithromycin therapy for Mycobacterium avium complex bacteremia.
Topics: AIDS-Related Opportunistic Infections; Bacteremia; Clarithromycin; Drug Administration Schedule; Humans; Mycobacterium avium-intracellulare Infection; Treatment Outcome | 1995 |
Clinical response to the addition of clarithromycin in Pneumocystis carinii pneumonia refractory to high dose co-trimoxazole.
Topics: Adult; AIDS-Related Opportunistic Infections; Clarithromycin; Drug Resistance, Microbial; Drug Therapy, Combination; Humans; Male; Pneumonia, Pneumocystis; Trimethoprim, Sulfamethoxazole Drug Combination | 1994 |
Quantitation of mycobacteria in blood specimens from patients with AIDS.
Topics: AIDS-Related Opportunistic Infections; Blood Preservation; Clarithromycin; Colony Count, Microbial; Culture Media; Dose-Response Relationship, Drug; Humans; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Rifabutin; Time Factors | 1994 |
Toxicity of clarithromycin in the treatment of Mycobacterium avium complex infection in a patient with AIDS.
Topics: AIDS-Related Opportunistic Infections; Clarithromycin; Corneal Opacity; Humans; Male; Middle Aged; Mycobacterium avium-intracellulare Infection | 1994 |
Treatment of experimental Toxoplasma gondii infection by clarithromycin-based combination therapy with minocycline or pyrimethamine.
Topics: AIDS-Related Opportunistic Infections; Animals; Clarithromycin; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Synergism; Drug Therapy, Combination; Female; Mice; Minocycline; Pyrimethamine; Sulfamethoxazole; Toxoplasma; Toxoplasmosis, Animal | 1994 |
Clarithromycin therapy for Mycobacterium avium complex disease in patients with AIDS: potential and problems.
Topics: AIDS-Related Opportunistic Infections; Bacteremia; Clarithromycin; Humans; Mycobacterium avium-intracellulare Infection | 1994 |
[Therapeutic alternatives for cases of cerebral toxoplasmosis in patients with AIDS: clarithromycin and atovaquone].
Topics: Adult; AIDS-Related Opportunistic Infections; Animals; Atovaquone; Clarithromycin; Clindamycin; Drug Therapy, Combination; Folic Acid; Humans; Male; Naphthoquinones; Pyrimethamine; Sulfadiazine; Toxoplasma; Toxoplasmosis, Cerebral | 1994 |
Mycobacterium avium strains resistant to clarithromycin and azithromycin.
Topics: AIDS-Related Opportunistic Infections; Azithromycin; Clarithromycin; Drug Resistance, Microbial; Humans; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection | 1994 |
Clarithromycin: a potent agent against infections due to Mycobacterium marinum.
Topics: Adult; AIDS-Related Opportunistic Infections; Clarithromycin; Connective Tissue Diseases; Female; Humans; Male; Middle Aged; Mycobacterium Infections, Nontuberculous; Skin Diseases, Bacterial | 1994 |
Hypopyon uveitis in patients with acquired immunodeficiency syndrome treated for systemic Mycobacterium avium complex infection with rifabutin.
Topics: Administration, Topical; Adult; AIDS-Related Opportunistic Infections; Anti-Inflammatory Agents; Child; Clarithromycin; Drug Therapy, Combination; Female; Glucocorticoids; Humans; Iridocyclitis; Male; Mycobacterium avium-intracellulare Infection; Retrospective Studies; Rifabutin; Suppuration; Uveitis, Anterior | 1994 |
AIDS patients have a new weapon against MAC infection.
Topics: Adult; AIDS-Related Opportunistic Infections; Child; Clarithromycin; Humans; Mycobacterium avium-intracellulare Infection; United States; United States Food and Drug Administration | 1994 |
Combination antibiotic treatment with clarithromycin for human immunodeficiency virus-associated Rhodococcus equi infection.
Topics: Actinomycetales Infections; Adult; AIDS-Related Opportunistic Infections; Clarithromycin; Drug Therapy, Combination; Female; Humans; Minocycline; Rhodococcus equi | 1993 |
Antibiotic gets FDA nod for MAC treatment.
Topics: AIDS-Related Opportunistic Infections; Clarithromycin; Humans; Mycobacterium avium-intracellulare Infection | 1994 |
[Primary prophylaxis of cerebral toxoplasmosis in AIDS with clarithromycin].
Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS-Related Opportunistic Infections; Clarithromycin; Humans; Male; Toxoplasmosis, Cerebral | 1993 |
Bronchopulmonary bacillary angiomatosis.
Topics: Administration, Oral; Adult; AIDS-Related Opportunistic Infections; Angiomatosis, Bacillary; Clarithromycin; Humans; Male; Respiratory Tract Infections | 1993 |
[Cerebral toxoplasmosis in AIDS. 73 cases. Clinical Epidemiology Group on AIDS in Aquitania].
Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS-Related Opportunistic Infections; Clarithromycin; Clindamycin; Drug Therapy, Combination; Female; France; Humans; Leucovorin; Male; Middle Aged; Pyrimethamine; Recurrence; Retrospective Studies; Sulfadiazine; Tomography, X-Ray Computed; Toxoplasmosis, Cerebral | 1993 |
Clarithromycin effectively treats infection in AIDS patients.
Topics: AIDS-Related Opportunistic Infections; Clarithromycin; Humans; Multicenter Studies as Topic; Mycobacterium avium-intracellulare Infection; Randomized Controlled Trials as Topic | 1993 |
A cutaneous lesion in a patient with AIDS: an unusual presentation of infection due to Mycobacterium avium complex.
Topics: Administration, Oral; Adult; AIDS-Related Opportunistic Infections; Ciprofloxacin; Clarithromycin; Drug Therapy, Combination; Ethambutol; Humans; Male; Mycobacterium avium; Mycobacterium avium-intracellulare Infection; Rifampin; Skin Diseases, Bacterial | 1993 |
Genetic basis of macrolide resistance in Mycobacterium avium isolated from patients with disseminated disease.
Topics: AIDS-Related Opportunistic Infections; Anti-Bacterial Agents; Azithromycin; Base Sequence; Clarithromycin; DNA, Bacterial; Drug Resistance, Microbial; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Nucleic Acid Conformation; Operon; Polymerase Chain Reaction; RNA, Bacterial; RNA, Messenger; RNA, Ribosomal, 23S | 1995 |
Postantibiotic effect of clarithromycin alone and combined with ethambutol against Mycobacterium avium complex.
Topics: AIDS-Related Opportunistic Infections; Anti-Bacterial Agents; Antitubercular Agents; Clarithromycin; Colony Count, Microbial; Drug Interactions; Ethambutol; Humans; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection | 1995 |
Clarithromycin-induced digoxin toxicity in a patient with AIDS.
Topics: Aged; AIDS-Related Opportunistic Infections; Anti-Bacterial Agents; Clarithromycin; Digoxin; Drug Interactions; Drug Therapy, Combination; Humans; Male | 1995 |
Azithromycin in the prophylaxis of opportunistic infections in AIDS.
Topics: AIDS-Related Opportunistic Infections; Anti-Bacterial Agents; Antibiotics, Antitubercular; Azithromycin; Clarithromycin; Clinical Trials as Topic; Humans; Mycobacterium avium-intracellulare Infection; Rifabutin | 1996 |
Mycobacterium avium disease: progress at last.
Topics: AIDS-Related Opportunistic Infections; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Microbial; Drug Resistance, Multiple; Drug Therapy, Combination; Humans; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Protein Synthesis Inhibitors | 1996 |
[Maintenance treatment of cerebral toxoplasmosis in AIDS: role of clarithromycin-minocycline combination].
Topics: Adult; AIDS-Related Opportunistic Infections; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Humans; Male; Minocycline; Toxoplasmosis, Cerebral | 1996 |
Uveitis during treatment of disseminated Mycobacterium avium-intracellulare complex infection with the combination of rifabutin, clarithromycin and ethambutol.
Topics: Adult; AIDS-Related Opportunistic Infections; Anti-Bacterial Agents; Antibiotics, Antitubercular; Clarithromycin; Drug Therapy, Combination; Ethambutol; Female; Humans; Male; Middle Aged; Mycobacterium avium-intracellulare Infection; Rifabutin; Uveitis | 1996 |
Disseminated varioliform pustular eruption due to Mycobacterium avium intracellulare in an HIV-infected patient.
Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS-Related Opportunistic Infections; Anti-Bacterial Agents; Clarithromycin; Humans; Male; Mycobacterium avium-intracellulare Infection; Skin Diseases, Bacterial | 1996 |
Clarithromycin prophylaxis against Cryptosporidium enteritis in patients with AIDS.
Topics: Acquired Immunodeficiency Syndrome; AIDS-Related Opportunistic Infections; Anti-Bacterial Agents; CD4 Lymphocyte Count; Clarithromycin; Cryptosporidiosis; Humans; Mycobacterium avium-intracellulare Infection; Retrospective Studies | 1996 |
A clarithromycin-induced myasthenic syndrome.
Topics: Adult; AIDS-Related Opportunistic Infections; Clarithromycin; Humans; Male; Myasthenia Gravis; Toxoplasmosis | 1996 |
Rifabutin-associated anterior uveitis in patients infected with human immunodeficiency virus.
Topics: Acute Disease; Administration, Oral; Adult; AIDS-Related Opportunistic Infections; Anti-Bacterial Agents; Antifungal Agents; Clarithromycin; Drug Therapy, Combination; Female; Fluconazole; Follow-Up Studies; Humans; Male; Middle Aged; Mycobacterium avium-intracellulare Infection; Rifabutin; Uveitis, Anterior; Visual Acuity | 1996 |
Antimycobacterial synergism of clarithromycin and rifabutin.
Topics: AIDS-Related Opportunistic Infections; Anti-Bacterial Agents; Antibiotics, Antitubercular; Clarithromycin; Drug Synergism; Drug Therapy, Combination; Humans; Microbial Sensitivity Tests; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Rifabutin | 1996 |
[Rifabutin-induced hypopyon iritis in HIV infection].
Topics: Adult; AIDS-Related Opportunistic Infections; Antibiotics, Antitubercular; Clarithromycin; Diagnosis, Differential; Drug Therapy, Combination; Ethambutol; Female; Humans; Iritis; Mycobacterium avium-intracellulare Infection; Rifabutin | 1996 |
Vinca alkaloids and macrolides in human immunodeficiency virus-related malignancies: a safe association.
Topics: AIDS-Related Opportunistic Infections; Antineoplastic Combined Chemotherapy Protocols; Clarithromycin; Humans; Sarcoma, Kaposi; Vinblastine; Vincristine | 1996 |
Rhodococcus or mycobacterium? An example of misdiagnosis in HIV infection.
Topics: Actinomycetales Infections; Adult; AIDS-Related Opportunistic Infections; Ciprofloxacin; Clarithromycin; Diagnostic Errors; Drug Therapy, Combination; Humans; Mycobacterium Infections; Pneumonia, Bacterial; Rhodococcus equi; Rifampin; Vancomycin | 1997 |
Uveitis associated with rifabutin and macrolide therapy for Mycobacterium avium intracellulare infection in AIDS patients.
Topics: Adult; AIDS-Related Opportunistic Infections; Anti-Bacterial Agents; Antibiotics, Antitubercular; Clarithromycin; Cohort Studies; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Mycobacterium avium-intracellulare Infection; Retrospective Studies; Rifabutin; Uveitis | 1996 |
[Management of atypical Mycobacterium infections in AIDS-patients].
Topics: Acquired Immunodeficiency Syndrome; AIDS-Related Opportunistic Infections; Clarithromycin; Humans; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Rifabutin | 1996 |
Isolated cutaneous Mycobacterium avium complex infection in AIDS.
Topics: Adult; AIDS-Related Opportunistic Infections; Anti-Bacterial Agents; Clarithromycin; Female; Humans; Mycobacterium avium-intracellulare Infection; Skin Diseases, Bacterial | 1997 |
Prophylaxis of mycobacterial infection and acquired drug resistance.
Topics: AIDS-Related Opportunistic Infections; Clarithromycin; Drug Resistance, Microbial; Gastrointestinal Diseases; Humans; Models, Biological; Mutation; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Rifabutin | 1997 |
[Pneumonia caused by Rhodococcus equi in patients with AIDS: difficulty in defining the most appropriate initial treatment].
Topics: Actinomycetales Infections; Adult; AIDS-Related Opportunistic Infections; Ciprofloxacin; Clarithromycin; Drug Resistance, Microbial; Drug Resistance, Multiple; Drug Therapy, Combination; Erythromycin; Gentamicins; Humans; Male; Microbial Sensitivity Tests; Pneumonia, Bacterial; Rhodococcus equi; Rifampin; Vancomycin | 1997 |
A retrospective comparison of clarithromycin versus rifampin in combination treatment for disseminated Mycobacterium avium complex disease in AIDS: clarithromycin decreases transfusion requirements.
Topics: Adult; Aged; AIDS-Related Opportunistic Infections; Anti-Bacterial Agents; Antibiotics, Antitubercular; Bacteremia; Blood Transfusion; Clarithromycin; Colorado; Community Health Centers; Drug Therapy, Combination; Evaluation Studies as Topic; Female; Humans; Male; Middle Aged; Mycobacterium avium-intracellulare Infection; Retrospective Studies; Rifampin; Survival Rate; Treatment Outcome | 1997 |
Clarithromycin-resistant Mycobacterium avium strain in a clarithromycin-naive AIDS patient.
Topics: Adult; AIDS-Related Opportunistic Infections; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Microbial; Humans; Male; Mycobacterium avium Complex | 1998 |
Possible effectiveness of clarithromycin and rifabutin for cryptosporidiosis chemoprophylaxis in HIV disease. HIV Outpatient Study (HOPS) Investigators.
Topics: Adult; AIDS-Related Opportunistic Infections; Anti-Bacterial Agents; Antibiotics, Antitubercular; Azithromycin; Clarithromycin; Cryptosporidiosis; Female; HIV Infections; Humans; Likelihood Functions; Male; Prospective Studies; Rifabutin; Statistics, Nonparametric | 1998 |
Paradoxical local response to therapy for Mycobacterium avium complex infection in four patients with AIDS.
Topics: Adult; AIDS-Related Opportunistic Infections; Amikacin; Anti-Bacterial Agents; Clarithromycin; Hepatomegaly; Humans; Lymph Nodes; Male; Mycobacterium avium-intracellulare Infection | 1998 |
AIDS-related Mycobacterium kansasii infection with initial resistance to clarithromycin.
Topics: Adult; AIDS-Related Opportunistic Infections; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Microbial; Humans; Mycobacterium Infections, Nontuberculous; Mycobacterium kansasii | 1998 |
Long-term outcomes of treatment of Mycobacterium avium complex bacteremia using a clarithromycin-containing regimen.
Topics: Adult; AIDS-Related Opportunistic Infections; Anti-Bacterial Agents; Antitubercular Agents; Bacteremia; Clarithromycin; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Male; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Retrospective Studies; Time Factors; Treatment Outcome | 1998 |
Preventing Mycobacterium avium complex in patients who are using protease inhibitors: a cost-effectiveness analysis.
Topics: Adult; AIDS-Related Opportunistic Infections; Anti-Bacterial Agents; Antibiotic Prophylaxis; Antibiotics, Antitubercular; Azithromycin; Clarithromycin; Cost-Benefit Analysis; Drug Therapy, Combination; Health Care Costs; HIV Infections; HIV Protease Inhibitors; Humans; Male; Markov Chains; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Quality of Life; Rifabutin; United States | 1998 |
Successful treatment of disseminated Mycobacterium simiae infection in AIDS patients.
Topics: Adolescent; Adult; AIDS-Related Opportunistic Infections; Anti-Infective Agents; Bacteremia; Ciprofloxacin; Clarithromycin; Disease-Free Survival; Drug Therapy, Combination; Ethambutol; Female; Humans; Male; Middle Aged; Mycobacterium Infections, Nontuberculous; Prognosis; Retrospective Studies; Treatment Outcome | 1998 |
Clarithromycin therapy for bacillary peliosis did not prevent bacillary angiomatosis.
Topics: Adult; AIDS-Related Opportunistic Infections; Angiomatosis, Bacillary; Anti-Bacterial Agents; Clarithromycin; Humans; Peliosis Hepatis | 1998 |
Clarithromycin prophylaxis for disseminated Mycobacterium avium complex infection--efficacy and acquired resistance.
Topics: AIDS-Related Opportunistic Infections; Anti-Bacterial Agents; Antitubercular Agents; Bacteremia; Clarithromycin; Drug Resistance, Microbial; Humans; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Survival Rate | 1998 |
Vancomycin-resistant enterococcal colonization in nonhospitalized HIV-infected patients.
Topics: Adult; AIDS-Related Opportunistic Infections; Amoxicillin; Anti-Bacterial Agents; Bisexuality; Black People; Cephalexin; Cephalosporins; Clarithromycin; Dicloxacillin; Doxycycline; Drug Resistance, Microbial; Enterococcus; Feces; Female; Gram-Positive Bacterial Infections; Homosexuality, Male; Humans; Male; Metronidazole; Middle Aged; Ofloxacin; Penicillins; Trimethoprim, Sulfamethoxazole Drug Combination; Vancomycin; White People | 1998 |
Long term treatment with clarithromycin for cryptosporidiosis and emergence of drug resistant disseminated infection due to Mycobacterium avium: case report.
Topics: Adult; AIDS-Related Opportunistic Infections; Anti-Bacterial Agents; Clarithromycin; Cryptosporidiosis; Drug Resistance, Microbial; Humans; Male; Mycobacterium avium; Tuberculosis | 1998 |
Postantibiotic effects of rifampin, amikacin, clarithromycin and ethambutol used alone or in various two-, three- and four-drug combinations against Mycobacterium avium.
Topics: AIDS-Related Opportunistic Infections; Amikacin; Anti-Bacterial Agents; Antitubercular Agents; Clarithromycin; Colony Count, Microbial; Drug Therapy, Combination; Ethambutol; Humans; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Radiometry; Rifampin | 1999 |
Altered expression profile of the surface glycopeptidolipids in drug-resistant clinical isolates of Mycobacterium avium complex.
Topics: AIDS-Related Opportunistic Infections; Anti-Bacterial Agents; Antitubercular Agents; Cell Wall; Chromatography, Thin Layer; Clarithromycin; Dose-Response Relationship, Drug; Drug Resistance, Microbial; Ethambutol; Galactans; Glycoconjugates; Humans; Lipopolysaccharides; Mass Spectrometry; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Polysaccharides; Polysaccharides, Bacterial; Surface Properties | 1999 |
Correlation of quantitative bone marrow and blood cultures in AIDS patients with disseminated Mycobacterium avium complex infection.
Topics: Adult; AIDS-Related Opportunistic Infections; Anti-Bacterial Agents; Antitubercular Agents; Bacteremia; Biopsy; Blood; Bone Marrow; Clarithromycin; Colony Count, Microbial; Culture Media; Ethambutol; Female; HIV-1; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; RNA, Viral | 1999 |
Prevention of disseminated Mycobacterium avium complex infection with reduced dose clarithromycin in patients with advanced HIV disease.
Topics: Adult; AIDS-Related Opportunistic Infections; Anti-Bacterial Agents; Antibiotic Prophylaxis; Antibiotics, Antitubercular; Blood; Clarithromycin; Female; Humans; Male; Microbial Sensitivity Tests; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Retrospective Studies; Rifabutin | 1999 |
Systematic validation of disease models for pharmacoeconomic evaluations. Swiss HIV Cohort Study.
Topics: AIDS-Related Opportunistic Infections; Anti-Bacterial Agents; Azithromycin; Clarithromycin; Computer Simulation; Disease Progression; Economics, Pharmaceutical; HIV Infections; Humans; Markov Chains; Mycobacterium avium-intracellulare Infection; Probability; Randomized Controlled Trials as Topic; Reproducibility of Results; Risk Factors; Switzerland | 1999 |
[Pseudotumoral abdominal granuloma concomitant with immune reconstitution after antiretroviral treatment].
Topics: Adrenal Cortex Hormones; Adult; AIDS-Related Opportunistic Infections; Anti-Bacterial Agents; Anti-HIV Agents; Antibiotics, Antitubercular; Antitubercular Agents; Biopsy; CD4 Lymphocyte Count; Clarithromycin; Drug Therapy, Combination; Ethambutol; Follow-Up Studies; Granuloma; HIV Infections; Humans; Lymphadenitis; Male; Mesentery; Mycobacterium avium; Peritoneal Diseases; Rifabutin; Time Factors; Tomography, X-Ray Computed; Tuberculosis | 2000 |
The cost-effectiveness of prophylaxis for Mycobacterium avium complex in AIDS.
Topics: AIDS-Related Opportunistic Infections; Azithromycin; Clarithromycin; Cost-Benefit Analysis; Drug Therapy, Combination; Humans; Mycobacterium avium-intracellulare Infection; Quality-Adjusted Life Years; Rifabutin | 1999 |
Clarithromycin-resistant mycobacterium avium is still susceptible to treatment with clarithromycin and is virulent in mice.
Topics: AIDS-Related Opportunistic Infections; Animals; Anti-Bacterial Agents; Antitubercular Agents; Clarithromycin; Drug Resistance, Microbial; Ethambutol; Humans; In Vitro Techniques; Macrophages; Mice; Mice, Inbred C57BL; Microbial Sensitivity Tests; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; RNA, Ribosomal, 23S | 2000 |
[HIV: a guide on management of seropositive patients].
Topics: AIDS-Related Opportunistic Infections; Anti-Bacterial Agents; Anti-HIV Agents; Clarithromycin; Drug Combinations; HIV Protease Inhibitors; HIV Seropositivity; Humans; Lopinavir; Nutrition Disorders; Patient Care Management; Physician-Patient Relations; Pyrimidinones; Quality of Life; Ritonavir | 2001 |
[Secondary prevention of opportunistic infections in HIV-infected patients].
Topics: AIDS-Related Opportunistic Infections; Anti-Bacterial Agents; Anti-Infective Agents; Antiprotozoal Agents; Antitubercular Agents; Antiviral Agents; Clarithromycin; Cytomegalovirus Infections; Drug Therapy, Combination; Ethambutol; Ganciclovir; Humans; Leucovorin; Mycobacterium avium-intracellulare Infection; Pneumonia, Pneumocystis; Pyrimethamine; Recurrence; Rifabutin; Sulfadiazine; Sulfamethoxazole; Toxoplasmosis; Trimethoprim | 2001 |
NIAID study rules out high-dose clarithromycin for AIDS-related MAC.
Topics: AIDS-Related Opportunistic Infections; Anti-Bacterial Agents; Clarithromycin; Humans; Mycobacterium avium-intracellulare Infection; Survival Analysis | 1996 |
New data suggest antibiotic clarithromycin is effective in prolonging life of AIDS patients.
Topics: AIDS-Related Opportunistic Infections; Anti-Bacterial Agents; Clarithromycin; Humans; Mycobacterium avium-intracellulare Infection; Quality of Life; Survival Rate | 1996 |
Advances in the diagnosis and treatment of Mycobacterium avium complex (MAC) disease.
Topics: AIDS-Related Opportunistic Infections; Anti-Bacterial Agents; Azithromycin; Bacteremia; Bone Marrow; Clarithromycin; Drug Therapy, Combination; Humans; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Rifabutin | 1994 |
Preventing opportunistic infections.
Topics: Acyclovir; AIDS-Related Opportunistic Infections; Clarithromycin; Clindamycin; Clinical Trials as Topic; Clotrimazole; Cytomegalovirus Infections; Dapsone; Fluconazole; Ganciclovir; Humans; Itraconazole; Leucovorin; Mycobacterium avium-intracellulare Infection; Mycoses; Pentamidine; Pneumonia, Pneumocystis; Pyrimethamine; Rifabutin; Toxoplasmosis; Trimethoprim, Sulfamethoxazole Drug Combination; Valacyclovir; Valine | 1995 |
Physician's aggressive preventive therapy differs.
Topics: AIDS-Related Opportunistic Infections; CD4 Lymphocyte Count; Clarithromycin; Cytomegalovirus Infections; Ethambutol; Humans; Meningitis, Cryptococcal; Mycobacterium avium-intracellulare Infection; New York City; Pneumonia, Pneumocystis; Trimethoprim, Sulfamethoxazole Drug Combination | 1995 |
New drug applications sought.
Topics: AIDS-Related Opportunistic Infections; Clarithromycin; Cytomegalovirus Retinitis; Drug Approval; Drug Implants; Drug Labeling; Foscarnet; Ganciclovir; Herpes Simplex; HIV Infections; Infusions, Intravenous; Mycobacterium avium-intracellulare Infection; Stavudine; United States; United States Food and Drug Administration | 1995 |
Advances in prevention and treatment of MAC.
Topics: AIDS-Related Opportunistic Infections; Azithromycin; CD4 Lymphocyte Count; Clarithromycin; Clinical Trials as Topic; Clofazimine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Ethambutol; Humans; Mycobacterium avium-intracellulare Infection; Rifabutin; Rifampin | 1995 |
Hold the big MAC.
Topics: AIDS-Related Opportunistic Infections; Anti-Bacterial Agents; Antibiotic Prophylaxis; Antibiotics, Antitubercular; Clarithromycin; Humans; Mycobacterium avium-intracellulare Infection; Rifabutin; Zidovudine | 1996 |
Macrolides, azalides, and streptogrammins.
Topics: AIDS-Related Opportunistic Infections; Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Bacteremia; Bacterial Infections; Clarithromycin; Clofazimine; Cryptosporidiosis; Drug Therapy, Combination; Duodenal Ulcer; Ethambutol; Humans; Microbial Sensitivity Tests; Mycobacterium avium-intracellulare Infection; Pneumonia; Smoking; Virginiamycin | 1996 |
Pot shots.
Topics: Acetylcysteine; AIDS-Related Opportunistic Infections; Animals; Anti-Bacterial Agents; Antitubercular Agents; Antiviral Agents; Cattle; CD4 Lymphocyte Count; China; Clarithromycin; Clinical Trials as Topic; Clofazimine; Cryptosporidiosis; Drug Combinations; Ethambutol; Expectorants; Glutathione; Hepatitis B; Humans; Immunoglobulins; Interferon-alpha; Italy; Leprostatic Agents; Mycobacterium avium-intracellulare Infection; Philippines; Protease Inhibitors; Survival Rate; Taiwan; Thymosin; Zidovudine | 1996 |
CPCRA researchers present OI studies at Vancouver.
Topics: Adult; AIDS-Related Opportunistic Infections; Anti-Bacterial Agents; Anti-Infective Agents; Antifungal Agents; Antitubercular Agents; Candidiasis; Child; Clarithromycin; Clinical Trials as Topic; DNA, Viral; Drug Therapy, Combination; Ethambutol; Female; Fluconazole; Humans; Isoniazid; Molluscum Contagiosum; Molluscum contagiosum virus; Multicenter Studies as Topic; Mycobacterium avium-intracellulare Infection; Ofloxacin; Patient Compliance; Pyrazinamide; Rifampin; Sequence Analysis, DNA; Tuberculosis | 1996 |
Recent development in the treatment and prevention of disseminated Mycobacterium avium complex (MAC).
Topics: AIDS-Related Opportunistic Infections; Anti-Bacterial Agents; Anti-Inflammatory Agents; Antibiotics, Antitubercular; Antifungal Agents; Azithromycin; Clarithromycin; Clinical Trials as Topic; Dexamethasone; Drug Interactions; Drug Resistance, Microbial; Drug Therapy, Combination; Ethambutol; Fluconazole; Humans; Mycobacterium avium-intracellulare Infection; Rifabutin; Risk Factors; Uveitis | 1996 |
OIs and cancers.
Topics: AIDS-Related Opportunistic Infections; Anti-Bacterial Agents; Clarithromycin; Homosexuality, Male; Humans; Male; Mycobacterium avium-intracellulare Infection; Nitrates; Saliva; Sarcoma, Kaposi; Semen | 1999 |
Possible bias of ascertainment in assessing chemoprophylaxis for cryptosporidiosis.
Topics: AIDS-Related Opportunistic Infections; Anti-Bacterial Agents; Bias; CD4 Lymphocyte Count; Clarithromycin; Cryptosporidiosis; Humans; Rifabutin | 2001 |
Reply to 'Possible bias of ascertainment in assessing chemoprophylaxis for cryptosporidiosis' by Holmberg and Moorman.
Topics: AIDS-Related Opportunistic Infections; Anti-Bacterial Agents; Antibiotic Prophylaxis; Bias; CD4 Lymphocyte Count; Clarithromycin; Cryptosporidiosis; Humans; Rifabutin | 2001 |
Chlamydia trachomatis and Mycobacterium tuberculosis lung infection in an HIV-positive homosexual man.
Topics: Adult; AIDS-Related Opportunistic Infections; Anti-Bacterial Agents; Antitubercular Agents; Chlamydia Infections; Chlamydia trachomatis; Clarithromycin; HIV Seropositivity; Homosexuality, Male; Humans; Male; Mycobacterium tuberculosis; Sexual Behavior; Treatment Outcome; Tuberculosis | 2001 |
Uveitis associated with rifabutin therapy.
Topics: Administration, Topical; Adult; AIDS-Related Opportunistic Infections; Anti-Bacterial Agents; Anti-Inflammatory Agents; Antibiotics, Antitubercular; Arthritis; Atropine; Clarithromycin; Drug Therapy, Combination; Glucocorticoids; Humans; Male; Middle Aged; Mycobacterium avium-intracellulare Infection; Retrospective Studies; Rifabutin; Uveitis, Anterior | 1995 |
[Treatment of atypical mycobacterium infections: current state and therapeutic perspectives].
Topics: AIDS-Related Opportunistic Infections; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Microbial; Drug Therapy, Combination; Humans; Mycobacterium Infections, Nontuberculous; Tuberculosis, Pulmonary | 1992 |